# AURLUMYN
> **NDA217933** · New Drug Application · Sponsor: BTG INTL · Approved 2024-02-13
## Drug
- **FDA Application Number:** NDA217933
- **Application type:** New Drug Application
- **Brand name:** AURLUMYN
- **Generic name:** ILOPROST
- **Active ingredients:** ILOPROST
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BTG INTL
- **Manufacturer:** BTG International Inc
- **First approval:** 2024-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217933)
---
*AI Analytics · CC0 1.0*